Radiation Injury and Mild Hyperbaric Oxygen Therapy (mHBOT)

What is Radiation Injury?

Radiation therapy targets tumors but can also harm nearby healthy tissues. This collateral damage is often due to reduced blood flow (ischemia) and direct cellular injury. Over time, irradiated tissues may become fibrotic, inflamed, and slow to heal【23†L267-L275】【2†L459-L466】. Patients may experience chronic wounds, swelling, or bone injuries (osteoradionecrosis) months or years after treatment.

For example, delayed radiation injury typically appears after a symptom-free interval of several months, leading to tissue fibrosis and impaired wound healing【23†L267-L275】. Researchers believe factors like obliterative endarteritis and cytokine-driven fibrosis contribute to these late effects【2†L459-L466】. In practice, managing such injuries often requires multidisciplinary care.

Potential Support from Hyperbaric Oxygen

Increased tissue oxygenation: Breathing pure oxygen under pressure raises blood and tissue oxygen levels, which can enhance cellular repair in hypoxic (low-oxygen) areas【6†L39-L44】【20†L216-L224】.
Angiogenesis stimulation: HBOT can promote new blood vessel formation (neovascularization) in irradiated tissues, improving circulation and nutrient delivery【2†L459-L466】【20†L216-L224】.
Enhanced wound healing: Clinical experience suggests HBOT supports healing of radiation-injured skin and soft tissue, helping close chronic wounds and ulcerations【23†L213-L222】【6†L39-L44】.
Bone recovery (osteoradionecrosis): HBOT is often used as an adjunct to surgery for radiation-damaged bone (e.g. jaw osteoradionecrosis), potentially reducing complications【17†L201-L205】【20†L197-L204】.
Reduced inflammation & infection: By improving oxygen levels, HBOT can mitigate chronic inflammation and bolster the immune response in irradiated areas, which also helps lower infection risk【20†L216-L224】【6†L39-L44】.
Systemic effects: Hyperbaric oxygen mobilizes stem cells that aid tissue repair and may reduce fibrosis by modulating cytokines (e.g. IL-1, TNF)【23†L287-L295】【20†L216-L224】.
Preventive use: Some clinics use HBOT protocols before or shortly after radiation to prevent delayed injury, although this approach is still under study【2†L374-L382】【27†L1-L4】.

Hyperbaric Oxygen Therapy (HBOT) in Radiation Care

Cancer radiation therapy is critical for treatment, but it can cause lasting injury to normal tissues. Late effects of radiation (such as poor wound healing, fibrosis or necrosis) often develop months after treatment【23†L267-L275】【20†L216-L224】. Mild Hyperbaric Oxygen Therapy (mHBOT) is a non-invasive therapy where patients breathe 100% oxygen in a pressurized chamber (typically 1.3–1.5 atmospheres absolute). This increases oxygen delivery to the whole body and specifically to hypoxic injury sites【6†L39-L44】【23†L287-L295】.

Mechanism: The extra oxygen dissolves in blood and diffuses into damaged areas, stimulating healing processes. Laboratory and animal studies show HBOT can boost angiogenesis, collagen formation, and stem-cell mobilization【23†L287-L295】【2†L459-L466】. Clinically, protocols often use pressures around 2.4–2.5 ATA for severe cases【20†L197-L204】; however, mHBOT centers use lower pressure (~1.3–1.5 ATA). While standard HBOT is well-supported by hyperbaric medicine societies, the efficacy of “mild” HBOT is still under evaluation【27†L1-L4】【27†L13-L17】. Some insurers have noted that devices below 1.4 ATA are “unproven” due to limited trials【27†L1-L4】【27†L19-L23】.

Clinical evidence: A Cochrane review of late radiation injuries (small studies up to 2006) found HBOT was associated with improved outcomes in head/neck and anorectal tissues, and reduced bone necrosis after dental extraction【17†L201-L205】. In practical terms, some patients experience significant symptom relief. For example, a Dutch study (2020) in sarcoma patients reported that HBOT improved chronic wound healing in ~69% of cases and reduced pain in ~75% of radiation injuries【23†L213-L222】. An Indian surgical oncology series also found HBOT to be a valuable adjunct in managing post-radiation wounds and osteoradionecrosis【12†L319-L324】.

Safety & Oversight: Hyperbaric oxygen is generally safe when administered in a controlled medical setting. Common side-effects (like ear pressure or mild vision changes) are manageable under supervision【20†L205-L214】. Importantly, current evidence does not show that HBOT promotes cancer growth or recurrence【20†L211-L215】. Because mHBOT devices use lower pressure, their potential benefits are less certain, and they should only be used under professional guidance.

Integrative approach: At Breath2Heal, mHBOT is offered as part of a comprehensive recovery plan. We work with patients’ doctors to integrate oxygen therapy with other supportive treatments (wound care, physical therapy, nutrition) when needed. The goal is to maximize healing of radiation damage while monitoring safety. Each program is tailored to the individual’s condition, using evidence-based protocols.

Our Approach and Expertise

Specialized experience: Our team includes clinicians trained in oncology and hyperbaric medicine, with experience managing complex late effects of cancer therapy.
Customized care: We design each mHBOT treatment plan based on the patient’s medical history, radiation exposure, and symptoms【20†L197-L204】.
Advanced facilities: Sessions take place in monitored hyperbaric chambers (certified for safety) under the supervision of trained staff.
Collaborative care: We coordinate with referring physicians. When appropriate, HBOT is combined with other therapies (e.g. medications, nutrition, physical therapy) to enhance healing.
Measured outcomes: Many patients report improvement in pain, wound healing, and function after HBOT as part of their recovery plan【12†L319-L324】【23†L213-L222】. We track patient progress to continually refine treatment.

Evidence Summary and References

Below is a summary comparison of key claims and the strength of supporting evidence. This is for informational purposes; please consult clinical experts for personalized advice.

Claim	Evidence Level	Key Sources
HBOT improves healing of radiation-damaged tissues	Moderate (multiple RCTs & reviews)	Cochrane review (LRTI), Randomized trials
HBOT reduces risk of osteoradionecrosis	Moderate (clinical studies & protocols)	Marx protocol, systematic analysis
HBOT enhances angiogenesis and oxygenation	High (animal/histology studies)	UHMS guidelines, imaging studies
“Mild” HBOT (<1.4 ATA) has proven effect	Preliminary/Low (limited data)	Insurer policy, anecdotal reports

timeline title Key Hyperbaric Oxygen Studies 1985 : Marx et al. - Established HBOT protocol for irradiated bone (20 pre-op + 10 post-op sessions)【20†L197-L204】 2006 : Bennett et al. (Cochrane) - Found improved outcomes with HBOT for head/neck LRTI【17†L201-L205】 2020 : Generaal et al. (PLOS) - Retrospective study: 68.8% wound healing improvement, 75% pain reduction with HBOT【23†L213-L222】 2025 : Alberta Guideline - Recommends HBOT for gynecologic radiation injuries, noting angiogenesis and anti-inflammatory effects【20†L216-L224】

References

National Cancer Institute – Definition of Hyperbaric Oxygen (Drug Dictionary). Describes HBOT principles, including radiosensitizing and tissue-healing roles【6†L39-L44】.
NCI Dictionary of Cancer Terms – “Hyperbaric Oxygen”. Defines HBOT uses in wound healing and as radiosensitizer【5†L45-L53】.
Undersea & Hyperbaric Medical Society – Chapter on Delayed Radiation Injury. Authoritative guide on HBOT for radiation injuries (angiogenesis, protocols, history)【2†L459-L466】【2†L474-L481】.
Generaal et al., *PLOS ONE* 2020. Retrospective study of HBOT for radiation injuries in sarcoma patients (68.8% wound improvement)【23†L213-L222】.
Alberta Health Services (Canada) – HBOT Guidelines for Radiation Injury (Nov 2025). Clinical guideline reviewing HBOT effects (angiogenesis, IL-1/TNF reduction)【20†L211-L220】【20†L216-L224】.
Korambayil et al., *Indian J Surg Oncol* 2020. Case series on HBOT for osteoradionecrosis and wounds (reported therapeutic benefit)【12†L319-L324】.
UnitedHealthcare Policy (2026). Notes that “mild HBOT” devices (<1.4 ATA) are considered unproven (insufficient evidence)【27†L1-L4】【27†L19-L23】.
Bennett MH, Feldmeier J, Hampson NB, et al. *Cochrane Database Syst Rev*. 2006;(2):CD005005. Hyperbaric Oxygen Therapy for late radiation tissue injury – meta-analysis of RCTs (improved outcomes in head/neck LRTI)【17†L201-L205】.